BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28677299)

  • 1. TdT expression in normal and neoplastic sebaceous cells.
    Tzorakoleftheraki SE; Iliadis A; Kostopoulos I; Koletsa T
    Histopathology; 2017 Dec; 71(6):985-988. PubMed ID: 28677299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of alpha-methylacyl-CoA racemase (P504S) in sebaceous neoplasms.
    Halsey MA; Calder KB; Mathew R; Schlauder S; Morgan MB
    J Cutan Pathol; 2010 Apr; 37(4):446-51. PubMed ID: 19638170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent TLE1 Expression in Cutaneous Neoplasms.
    Xiong Y; Dresser K; Cornejo KM
    Am J Dermatopathol; 2019 Jan; 41(1):1-6. PubMed ID: 30608261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Malic Enzymes in Sebaceous Lesions.
    Su TF; Gao HW
    Am J Dermatopathol; 2016 Aug; 38(8):580-5. PubMed ID: 26381116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation.
    Bayer-Garner IB; Givens V; Smoller B
    Am J Dermatopathol; 1999 Oct; 21(5):426-31. PubMed ID: 10535570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
    Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
    Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures.
    Ng JKM; Choi PCL; Chow C; Li JJX; Chan AWS; Cheung CMT; Ip ECC; Ng HK; To KF
    Pathology; 2022 Oct; 54(6):721-728. PubMed ID: 35644638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sebaceous carcinoma: an immunohistochemical reappraisal.
    Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
    Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry in ocular carcinomas.
    Sramek B; Lisle A; Loy T
    J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Lipoxygenase-2 expression in benign and neoplastic sebaceous glands and other cutaneous adnexa.
    Shappell SB; Keeney DS; Zhang J; Page R; Olson SJ; Brash AR
    J Invest Dermatol; 2001 Jul; 117(1):36-43. PubMed ID: 11442747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sebaceoma and related neoplasms with sebaceous differentiation: a clinicopathologic study of 30 cases.
    Misago N; Mihara I; Ansai S; Narisawa Y
    Am J Dermatopathol; 2002 Aug; 24(4):294-304. PubMed ID: 12142607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland marker.
    Metze D; Soyer HP; Zelger B; Neumaier M; Grunert F; Hartig C; Amann U; Bhardwaj R; Wagener C; Luger T
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):735-44. PubMed ID: 8632066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
    Mittal R; Araujo I; Czanner G; Coupland SE
    Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of oestrogen and progesterone receptors in canine sebaceous gland tumours.
    Ginel PJ; Lucena R; Millán Y; González-Medina S; Guil S; García-Monterde J; de los Monteros AE; de las Mulas JM
    Vet Dermatol; 2010 Jun; 21(3):297-302. PubMed ID: 20030798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD10 in basal cell carcinoma.
    Yada K; Kashima K; Daa T; Kitano S; Fujiwara S; Yokoyama S
    Am J Dermatopathol; 2004 Dec; 26(6):463-71. PubMed ID: 15618927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of apocrine duct squamous cell carcinoma, basal cell epithelioma and sebaceous cell differentiation].
    Kishimoto S; Arita T; Koishi K; Hirano S; Tsuboi T
    Nihon Hifuka Gakkai Zasshi; 1987 Apr; 97(5):537-44. PubMed ID: 3613216
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative clinicopathological study of intraoral sebaceous hyperplasia and sebaceous adenoma.
    Azevedo RS; Almeida OP; Netto JN; Miranda AM; Santos TC; Della Coletta R; Lopes MA; Pires FR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):100-4. PubMed ID: 19101492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.